Editor

David Chen

Editor · drug development, then telehealth

This index is edited by someone who has worked on both sides of the market it measures — years inside drug development, and a period previously spent helping run a telehealth practice that prescribed GLP-1 medications. That is why the site is built around what a seller actually bills rather than what it advertises: from the inside, the gap between those two numbers is not a mystery.

The editor is not a licensed clinician, and this site gives no medical advice. Every clinical statement here is sourced to FDA prescribing information or to a named paper whose PMID has been verified against the record. Where the label is silent, the page says the label is silent rather than filling the gap.

The same editor writes Compounded Tirzepatide and Compounded Semaglutide. They are two sites because they cover two different drugs, and each one is priced on its own: source evidence is collected for the specific medication, and a price found on one site is never copied across to the other.

Think of the site as a directory of seller prices and purchasing terms. It summarizes plans, billing and stated service areas, with source links and evidence dates where available. Prices are converted to a 30.4375-day calendar month when the charge and billing interval are known. Advertised-only quotes and unresolved details remain labeled rather than being presented as confirmed totals. The method is at /how-we-verify, and the dataset is downloadable.

What this site covers

This index lists 384 US sellers of compounded tirzepatide, with source evidence and calendar-month equivalents where the billing terms are known. The verification method explains when a quote can be converted to a monthly cost. Advertised-only prices remain labeled, and missing information stays unresolved.

Nothing on this site is medical advice, and the editor is not a licensed clinician. Clinical statements are sourced to the approved product’s label or to a named paper with its PMID verified against the record — see the medical disclaimer and the editorial policy.